These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17075557)

  • 21. Evolving perspectives on neurobiological research on the addictions: celebration of the 30th anniversary of NIDA.
    Kreek MJ; Schlussman SD; Bart G; Laforge KS; Butelman ER
    Neuropharmacology; 2004; 47 Suppl 1():324-44. PubMed ID: 15464148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The genetics of the opioid system and specific drug addictions.
    Levran O; Yuferov V; Kreek MJ
    Hum Genet; 2012 Jun; 131(6):823-42. PubMed ID: 22547174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability.
    Ouzir M; Errami M
    Pharmacol Biochem Behav; 2016 Sep; 148():59-68. PubMed ID: 27306332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The neurobiology of drug addiction.
    Koob GF; Nestler EJ
    J Neuropsychiatry Clin Neurosci; 1997; 9(3):482-97. PubMed ID: 9276849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor polymorphisms and opioid abuse.
    Lee NM; Smith AP
    Pharmacogenomics; 2002 Mar; 3(2):219-27. PubMed ID: 11972443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genes associated with addiction: alcoholism, opiate, and cocaine addiction.
    Kreek MJ; Nielsen DA; LaForge KS
    Neuromolecular Med; 2004; 5(1):85-108. PubMed ID: 15001815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurobiology of addiction: insight from neurochemical imaging.
    Urban NB; Martinez D
    Psychiatr Clin North Am; 2012 Jun; 35(2):521-41. PubMed ID: 22640769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Opioid abuse and brain gene expression.
    Przewlocki R
    Eur J Pharmacol; 2004 Oct; 500(1-3):331-49. PubMed ID: 15464044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug addiction: the neurobiology of disrupted self-control.
    Baler RD; Volkow ND
    Trends Mol Med; 2006 Dec; 12(12):559-66. PubMed ID: 17070107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular neurobiology of drug addiction.
    Nestler EJ
    Neuropsychopharmacology; 1994 Oct; 11(2):77-87. PubMed ID: 7840866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous opioids and addiction to alcohol and other drugs of abuse.
    Gianoulakis C
    Curr Top Med Chem; 2004; 4(1):39-50. PubMed ID: 14754375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis.
    Blum K; Gold MS
    Med Hypotheses; 2011 Apr; 76(4):576-84. PubMed ID: 21306831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosis and depression - a neurobiological view.
    Pregelj P
    Psychiatr Danub; 2009 Sep; 21 Suppl 1():102-5. PubMed ID: 19789492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The addictive brain: all roads lead to dopamine.
    Blum K; Chen AL; Giordano J; Borsten J; Chen TJ; Hauser M; Simpatico T; Femino J; Braverman ER; Barh D
    J Psychoactive Drugs; 2012; 44(2):134-43. PubMed ID: 22880541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influences of social reward experience on behavioral responses to drugs of abuse: Review of shared and divergent neural plasticity mechanisms for sexual reward and drugs of abuse.
    Beloate LN; Coolen LM
    Neurosci Biobehav Rev; 2017 Dec; 83():356-372. PubMed ID: 29108963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent understanding in the mechanisms of addiction.
    Kalivas PW
    Curr Psychiatry Rep; 2004 Oct; 6(5):347-51. PubMed ID: 15355757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurobiology of addiction. Toward the development of new therapies.
    Koob GF
    Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming qEEG abnormalities and reward gene deficits during protracted abstinence in male psychostimulant and polydrug abusers utilizing putative dopamine Dâ‚‚ agonist therapy: part 2.
    Blum K; Chen TJ; Morse S; Giordano J; Chen AL; Thompson J; Allen C; Smolen A; Lubar J; Stice E; Downs BW; Waite RL; Madigan MA; Kerner M; Fornari F; Braverman ER
    Postgrad Med; 2010 Nov; 122(6):214-26. PubMed ID: 21084796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length polymorphism appears more frequently in polysubstance abusers.
    Smith SS; O'Hara BF; Persico AM; Gorelick DA; Newlin DB; Vlahov D; Solomon L; Pickens R; Uhl GR
    Arch Gen Psychiatry; 1992 Sep; 49(9):723-7. PubMed ID: 1355337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reward loss and addiction: Opportunities for cross-pollination.
    Ortega LA; Solano JL; Torres C; Papini MR
    Pharmacol Biochem Behav; 2017 Mar; 154():39-52. PubMed ID: 28174137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.